technetium tc 99m sestamibi has been researched along with Hyperemia in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belardinelli, L; Dione, DP; Jadbabaie, F; Mekkaoui, C; Meoli, DF; Purushothaman, K; Sinusas, AJ | 1 |
Dilsizian, V | 1 |
Bax, M; Chamuleau, SA; Damman, P; Delewi, R; Meuwissen, M; Nolte, F; Piek, JJ; Siebes, M; Spaan, JA; Tijssen, JG; van de Hoef, TP; Voskuil, M | 1 |
Brown, KA; Haber, SB; Heller, GV; Landin, RJ | 1 |
Heo, J; Iskandrian, AE; Kegel, JG; Ogilby, JD | 1 |
Humen, DP; Nigam, A | 1 |
Bouvier, F; Höjer, J; Hulting, J; Jensen-Urstad, M; Ruiz, H; Samad, B | 1 |
Bin, JP; Coggins, M; Jayawera, AR; Kaul, S; Le, E; Wei, K | 1 |
Bunko, H; Fujino, S; Matsunari, I; Nakajima, K; Okazaki, H; Saga, T; Taki, J; Tonami, N | 1 |
2 trial(s) available for technetium tc 99m sestamibi and Hyperemia
Article | Year |
---|---|
Diagnostic accuracy of combined intracoronary pressure and flow velocity information during baseline conditions: adenosine-free assessment of functional coronary lesion severity.
Topics: Adenosine; Aged; Blood Flow Velocity; Blood Pressure; Cardiac Catheterization; Coronary Circulation; Coronary Disease; Female; Humans; Hyperemia; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Severity of Illness Index; Technetium Tc 99m Sestamibi; Vasodilator Agents | 2012 |
Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS).
Topics: Angina, Unstable; Blood Pressure; Coronary Circulation; Death, Sudden, Cardiac; Dipyridamole; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Hyperemia; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Radiopharmaceuticals; Recurrence; Risk Assessment; Safety; Survival Rate; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1997 |
7 other study(ies) available for technetium tc 99m sestamibi and Hyperemia
Article | Year |
---|---|
Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Dogs; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
Connectivity of radiotracers to vasodilators is thallium the missing link?
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Dogs; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
Correlation between hemodynamic changes and tomographic sestamibi imaging during dipyridamole-induced coronary hyperemia.
Topics: Adult; Aged; Blood Pressure; Coronary Angiography; Coronary Disease; Dipyridamole; Female; Heart Diseases; Hemodynamics; Humans; Hyperemia; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1998 |
Prognostic value of myocardial perfusion imaging with exercise and/or dipyridamole hyperemia in patients with preexisting left bundle branch block.
Topics: Adult; Aged; Aged, 80 and over; Bundle-Branch Block; Coronary Circulation; Dipyridamole; Exercise Test; Female; Heart; Humans; Hyperemia; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1998 |
Myocardial perfusion scintigraphy (SPECT) during adenosine stress can be performed safely early on after thrombolytic therapy in acute myocardial infarction.
Topics: Adenosine; Aged; Dyspnea; Electrocardiography; Exercise Test; Female; Heart Block; Heart Rate; Humans; Hyperemia; Male; Middle Aged; Myocardial Infarction; Technetium Tc 99m Sestamibi; Thrombolytic Therapy; Tomography, Emission-Computed, Single-Photon | 1998 |
Mechanism of reversible (99m)Tc-sestamibi perfusion defects during pharmacologically induced vasodilatation.
Topics: Adenosine; Animals; Blood Flow Velocity; Blood Volume; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Echocardiography; Heart; Hemodynamics; Hyperemia; Radionuclide Imaging; Reference Values; Regression Analysis; Technetium Tc 99m Sestamibi; Tissue Distribution; Vascular Resistance; Vasodilation | 2001 |
(99m)Tc-sestamibi retention characteristics during pharmacologic hyperemia in human myocardium: comparison with coronary flow reserve measured by Doppler flowire.
Topics: Adenosine Triphosphate; Aged; Blood Flow Velocity; Coronary Circulation; Female; Humans; Hyperemia; Male; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography, Doppler; Vasodilation | 2001 |